The Xolair Pregnancy Registry (EXPECT): Perinatal outcomes among pregnant women with asthma treated with omalizumab (Xolair) compared against those of a cohort of pregnant women with moderate-to-severe asthma

Namazy, JA; Blais, L; Andrews, EB; Scheuerle, AE; Cabana, MD; Thorp, JM; Veith, JH; Umetsu, DT; Sun, D; Kaufman, DG; Covington, DL; Mukhopadhyay, S; Fogel, RB; Lopez-Leon, S; Spain, V

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019; 143 (2): AB103